5366

543329

WINDLAS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

WINDLAS BIOTECH LIMITED Share Price Today

WINDLAS BIOTECH LIMITED is currently trading at ₹854, down by ₹9.79 from the previous close. The stock touched an intraday high of ₹874.00 and a low of ₹854.00 during the latest trading session. Over the past one year, WINDLAS BIOTECH LIMITED has delivered a loss of 7.16%, while the stock has gained 6.33% in the last one month.

WINDLAS BIOTECH LIMITED performance

Today’s low Today’s high
₹ 854.00 ₹ 874.00
₹ 859.00
52 week low 52 week high
₹ 697.40 ₹ 1097.90
₹ 859.00
Open Price ₹ 866.40
Prev. Close ₹ 863.80
Volume (Shares) 24005.00
Total traded value ₹ 206.20
Upper Circuit ₹ 1036.55
Lower Circuit ₹ 691.05
info

Investment Returns

Over 1 Month 6.33% Over 3 Months 13.59% Over 6 Months 4.92% Over 1 Year -7.16%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

WINDLAS BIOTECH LIMITED fundamentals


  • Market cap (Cr) 1,772.70
  • P/E Ratio (TTM) 26.73
  • Beta 0.81
  • Book Value / share 281.34
  • Return on equity 12.69%
  • EPS (TTM) 32.19
  • Dividend yield 0.75%
  • Net profit/quarter (Cr) 16.02
info icon alternate text
  • Market cap (Cr) 1,775.30
  • P/E Ratio (TTM) 26.73
  • Beta 0.72
  • Book Value / share 281.34
  • Return on equity 12.69%
  • EPS (TTM) 32.19
  • Dividend yield 0.75%
  • Net profit/quarter (Cr) 16.02
info icon alternate text

WINDLAS BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 238.50
Operating Expense 222.73
Net Profit 16.02
Net Profit Margin (%) 6.71
Earnings Per Share (EPS) 7.60
EBITDA 29.64
Effective Tax Rate (%) 20.58
Particulars DEC 2025 (Values in Cr)
Revenue 233.10
Operating Expense 217.70
Net Profit 14.95
Net Profit Margin (%) 6.41
Earnings Per Share (EPS) 7.09
EBITDA 28.90
Effective Tax Rate (%) 24.94
Particulars SEP 2025 (Values in Cr)
Revenue 222.40
Operating Expense 202.46
Net Profit 17.80
Net Profit Margin (%) 8.00
Earnings Per Share (EPS) 8.48
EBITDA 32.21
Effective Tax Rate (%) 24.54
Particulars JUN 2025 (Values in Cr)
Revenue 210.09
Operating Expense 192.07
Net Profit 17.67
Net Profit Margin (%) 8.41
Earnings Per Share (EPS) 8.43
EBITDA 31.77
Effective Tax Rate (%) 24.03
Particulars MAR 2025 (Values in Cr)
Revenue 202.71
Operating Expense 186.82
Net Profit 16.29
Net Profit Margin (%) 8.03
Earnings Per Share (EPS) 7.77
EBITDA 30.49
Effective Tax Rate (%) 21.79
Particulars MAR 2026 (Values in Cr)
Revenue 904.09
Operating Expense 834.97
Net Profit 66.44
Net Profit Margin (%) 7.34
Earnings Per Share (EPS) 31.59
EBITDA 122.50
Effective Tax Rate (%) 23.58
Particulars MAR 2025 (Values in Cr)
Revenue 759.88
Operating Expense 698.13
Net Profit 60.65
Net Profit Margin (%) 7.98
Earnings Per Share (EPS) 29.03
EBITDA 111.75
Effective Tax Rate (%) 23.61
Particulars MAR 2024 (Values in Cr)
Revenue 630.96
Operating Expense 567.40
Net Profit 58.14
Net Profit Margin (%) 9.21
Earnings Per Share (EPS) 27.95
EBITDA 91.55
Effective Tax Rate (%) 24.51
Particulars MAR 2023 (Values in Cr)
Revenue 513.08
Operating Expense 466.00
Net Profit 42.64
Net Profit Margin (%) 8.31
Earnings Per Share (EPS) 19.71
EBITDA 70.21
Effective Tax Rate (%) 25.25
Particulars MAR 2022 (Values in Cr)
Revenue 465.93
Operating Expense 426.60
Net Profit 38.56
Net Profit Margin (%) 8.27
Earnings Per Share (EPS) 18.81
EBITDA 59.61
Effective Tax Rate (%) 16.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 241.30
ROE % 12.76
ROCE % 16.87
Total Debt to Total Equity 0.04
EBITDA Margin 14.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 216.34
ROE % 13.66
ROCE % 18.07
Total Debt to Total Equity 0.01
EBITDA Margin 14.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.24
ROE % 10.70
ROCE % 14.23
Total Debt to Total Equity 0.01
EBITDA Margin 13.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 181.14
ROE % 12.83
ROCE % 14.77
Total Debt to Total Equity 0.07
EBITDA Margin 12.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 310.59
ROE % 15.19
ROCE % 18.88
Total Debt to Total Equity 0.15
EBITDA Margin 13.47
Particulars MAR 2025 (Values in Cr)
Book Value / Share 241.31
ROE % 12.69
ROCE % 16.79
Total Debt to Total Equity 0.04
EBITDA Margin 14.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 216.51
ROE % 13.63
ROCE % 18.03
Total Debt to Total Equity 0.01
EBITDA Margin 14.51
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.42
ROE % 10.69
ROCE % 14.22
Total Debt to Total Equity 0.01
EBITDA Margin 13.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 181.30
ROE % 12.98
ROCE % 14.91
Total Debt to Total Equity 0.07
EBITDA Margin 12.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 310.39
ROE % 9.39
ROCE % 18.75
Total Debt to Total Equity 0.14
EBITDA Margin 13.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 15.92
Total Assets 760.45
Total Liabilities 760.45
Total Equity 505.77
Share Outstanding 2
Price to Book Ratio 4.31
Return on Assets (%) 8.02
Return on Capital (%) 11.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.94
Total Assets 626.20
Total Liabilities 626.20
Total Equity 449.93
Share Outstanding 2
Price to Book Ratio 2.37
Return on Assets (%) 9.29
Return on Capital (%) 12.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.45
Total Assets 528.97
Total Liabilities 528.97
Total Equity 402.27
Share Outstanding 2
Price to Book Ratio 1.17
Return on Assets (%) 8.05
Return on Capital (%) 10.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 113.82
Total Assets 491.01
Total Liabilities 491.01
Total Equity 394.77
Share Outstanding 2
Price to Book Ratio 1.16
Return on Assets (%) 7.75
Return on Capital (%) 9.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 31.11
Total Assets 296.12
Total Liabilities 296.12
Total Equity 199.11
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 5.34
Return on Capital (%) 6.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 15.92
Total Assets 760.44
Total Liabilities 760.44
Total Equity 505.78
Share Outstanding 2
Price to Book Ratio 4.31
Return on Assets (%) 7.97
Return on Capital (%) 11.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.89
Total Assets 626.15
Total Liabilities 626.15
Total Equity 450.29
Share Outstanding 2
Price to Book Ratio 2.37
Return on Assets (%) 9.28
Return on Capital (%) 12.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.45
Total Assets 529.00
Total Liabilities 529.00
Total Equity 402.66
Share Outstanding 2
Price to Book Ratio 1.17
Return on Assets (%) 8.06
Return on Capital (%) 10.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 113.80
Total Assets 491.02
Total Liabilities 491.02
Total Equity 395.12
Share Outstanding 2
Price to Book Ratio 1.16
Return on Assets (%) 7.85
Return on Capital (%) 9.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 30.95
Total Assets 295.99
Total Liabilities 295.99
Total Equity 198.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.69
Return on Capital (%) 2.18
Particulars MAR 2025 (Values in Cr)
Net Income 79.75
Cash from Operations 89.07
Cash from Investing -74.06
Cash from Financing 1.01
Net change in Cash -4.86
Free Cash Flow 141.26
Particulars MAR 2024 (Values in Cr)
Net Income 77.09
Cash from Operations 127.60
Cash from Investing -92.06
Cash from Financing -15.29
Net change in Cash 1.60
Free Cash Flow 165.29
Particulars MAR 2023 (Values in Cr)
Net Income 57.03
Cash from Operations 70.68
Cash from Investing -14.11
Cash from Financing -43.73
Net change in Cash 3.11
Free Cash Flow 141.57
Particulars MAR 2022 (Values in Cr)
Net Income 45.56
Cash from Operations 18.01
Cash from Investing -154.57
Cash from Financing 130.08
Net change in Cash -15.36
Free Cash Flow 32.81
Particulars MAR 2021 (Values in Cr)
Net Income 21.74
Cash from Operations 17.98
Cash from Investing -20.19
Cash from Financing 0.77
Net change in Cash -7.96
Free Cash Flow 23.83
Particulars MAR 2025 (Values in Cr)
Net Income 79.39
Cash from Operations 89.09
Cash from Investing -74.06
Cash from Financing 1.01
Net change in Cash -4.81
Free Cash Flow 141.29
Particulars MAR 2024 (Values in Cr)
Net Income 77.02
Cash from Operations 127.53
Cash from Investing -92.06
Cash from Financing -15.28
Net change in Cash 1.55
Free Cash Flow 165.21
Particulars MAR 2023 (Values in Cr)
Net Income 57.05
Cash from Operations 70.69
Cash from Investing -14.11
Cash from Financing -43.73
Net change in Cash 3.13
Free Cash Flow 141.58
Particulars MAR 2022 (Values in Cr)
Net Income 46.03
Cash from Operations 17.87
Cash from Investing -154.30
Cash from Financing 130.08
Net change in Cash -15.22
Free Cash Flow 32.67
Particulars MAR 2021 (Values in Cr)
Net Income 11.18
Cash from Operations 17.98
Cash from Investing -20.19
Cash from Financing 0.77
Net change in Cash -7.96
Free Cash Flow 23.82
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

WINDLAS BIOTECH LIMITED shareholding pattern

Holding
25.5%
63.31%
0.98%
10.19%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

WINDLAS BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
859.00 -0.55 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 850.80
  • 26 Days 826.40
  • 10 Days 840.20
  • 50 Days 818.40
  • 12 Days 837.30
  • 100 Days 815.80
  • 20 Days 829.60
  • 200 Days 833.30
813.68 PIVOT
First Support 798.37 First Resistance 822.97 Second Support 789.08 Second Resistance 838.28 Third Support 773.77 Third Resistance 847.57
RSI 50.58 ADX 33.47 MACD 1.85 Williams % R -54.50 Commodity Channel Index (CCI) 12.23
Date 2026-06-19 Week 27011.00 Same Day 27842.00 Month 39571.00
1 Year 0.81 3 Year 0.90
Over 1 Month
6.33% down
Over 1 Year
-7.16% down
Over 3 Months
13.59% down
Over 3 Years
38.16% down
Over 6 Months
4.92% down
Over 5 Years
14.91% down

WINDLAS BIOTECH LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Jul 2025 5.8 Final 21 Jul 2025 Equity shares
17 Sep 2024 5.5 Final 17 Sep 2024 Equity shares
05 Sep 2023 4.0 Final 05 Sep 2023 Equity shares
09 Sep 2022 3.5 Final 12 Sep 2022 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
21 Jul 2025 5.8 Final 21 Jul 2025 Equity shares
17 Sep 2024 5.5 Final 17 Sep 2024 Equity shares
05 Sep 2023 4.0 Final 05 Sep 2023 Equity shares
09 Sep 2022 3.5 Final 12 Sep 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Windlas Biotech Ltd?

Answer Field

Windlas Biotech Ltd share price is for NSE ₹ 854.00 & for BSE ₹ 855.00 as on Jun 25 2026 03:29 PM.

What is the Market Cap of Windlas Biotech Ltd Share?

Answer Field

The market cap of Windlas Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:29 PM.

What is the 52 Week High and Low of Windlas Biotech Ltd?

Answer Field

The 52 Week High and Low of Windlas Biotech Ltd for NSE is ₹ 1,097.90 and ₹ 697.40 and for BSE is ₹ 1,095.00 and ₹ 699.35.

What is 1 year return for Windlas Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -5.28%.

What is the P/E Ratio of Windlas Biotech Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM the price-to-earnings (PE) ratio for Windlas Biotech Ltd share is 26.73.

What is the PB ratio of Windlas Biotech Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM, the price-to-book (PB) ratio for Windlas Biotech Ltd share is 281.34.

How to Buy Windlas Biotech Ltd Share?

Answer Field

You can trade in Windlas Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Windlas Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Windlas Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Windlas Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|